Mannatech (NASDAQ:MTEX) Announces Quarterly Earnings Results

Mannatech (NASDAQ:MTEX) announced its quarterly earnings results on Wednesday. The company reported ($5.94) earnings per share for the quarter, FiscalAI reports. The company had revenue of $26.64 million for the quarter. Mannatech had a negative net margin of 1.50% and a negative return on equity of 22.75%.

Mannatech Price Performance

Shares of MTEX traded up $0.12 during trading hours on Wednesday, hitting $4.96. 3,335 shares of the stock were exchanged, compared to its average volume of 17,002. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.56 and a current ratio of 1.13. Mannatech has a 12-month low of $4.66 and a 12-month high of $12.45. The company has a market cap of $9.42 million, a price-to-earnings ratio of -5.77 and a beta of 0.82. The stock’s 50-day moving average price is $6.69 and its two-hundred day moving average price is $8.02.

Analyst Ratings Changes

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Mannatech in a research report on Monday, December 22nd. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Mannatech presently has an average rating of “Sell”.

About Mannatech

Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.

The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.